New Researches In Treatment Of Rheumatoid Arthritis. Part 2 of 3

New Researches In Treatment Of Rheumatoid Arthritis – Part 2 of 3

The study included more than 6200 rheumatoid arthritis patients who started treatment by taking either tumor necrosis factor inhibitors (TNFi) or non-TNFi biologics. In the TNFi group, the percentages of patients who continued taking their medications were about 82 percent at six months, 68 percent at 12 months and 52 percent at 24 months.

arthritis

In the non-TNFi group, the percentages for those corresponding leisure periods were about 81 percent, 63 percent and 46 percent, respectively. The usual time to medication discontinuation was 26,5 months in the TNFi group and 20,5 months in the non-TNFi group, the investigators found.

Parts: 1 2 3

About KrystleBanks

News from Dr. Krystle Banks, Construction equipment operator
This entry was posted in Soundness and tagged , , . Bookmark the permalink.

2 Responses to New Researches In Treatment Of Rheumatoid Arthritis. Part 2 of 3

  1. Pingback: New Researches In Treatment Of Rheumatoid Arthritis. Part 1 of 3 | Paul Winkler MD

  2. Pingback: New Researches In Treatment Of Rheumatoid Arthritis. Part 3 of 3 | Paul Winkler MD

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s